eComment: A comparison of the safety of aprotinin and tranexamic acid in cardiac surgery.
Koniari
Ioanna
I
Department of Cardiothoracic Surgery, University Hospital of Patras, 22500 Rion Patras, Greece.
Apostolakis
Efstratios
E
Mandellou
Martha
M
Martha
Mandellou
M
D000933:Antifibrinolytic Agents / Q000009:adverse effects*; D007611:Aprotinin / Q000009:adverse effects*; D016063:Blood Loss, Surgical / Q000401:mortality / Q000517:prevention & control*; D001803:Blood Transfusion; D006348:Cardiac Surgical Procedures / Q000009:adverse effects / Q000401:mortality*; D003257:Consumer Product Safety; D019317:Evidence-Based Medicine; D006801:Humans; D016017:Odds Ratio; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D014148:Tranexamic Acid / Q000009:adverse effects*; D016896:Treatment Outcome
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid; D007611:Aprotinin